Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

White Paper on European Patient Needs and Suggestions on Chronic Type 2 Inflammation of Airways and Skin by EUFOREA
Louise De Prins, Ulrike Raap, Tara Mueller, et al.
Frontiers in Allergy (2022) Vol. 3
Open Access | Times Cited: 28

Showing 1-25 of 28 citing articles:

EPOS/EUFOREA update on indication and evaluation of Biologics in Chronic Rhinosinusitis with Nasal Polyps 2023
W.J. Fokkens, A-S Viskens, V. Backer, et al.
Rhinology Journal (2023)
Open Access | Times Cited: 156
New insights into the pathophysiology and therapeutic targets of asthma and comorbid chronic rhinosinusitis with or without nasal polyposis
Ilja Střı́ž, Korneliusz Golebski, Zuzana Střížová, et al.
Clinical Science (2023) Vol. 137, Iss. 9, pp. 727-753
Open Access | Times Cited: 33
EUFOREA/EPOS2020 statement on the clinical considerations for chronic rhinosinusitis with nasal polyps care
Peter W. Hellings, Isam Alobid, Wilma Terezinha Anselmo‐Lima, et al.
Allergy (2023) Vol. 79, Iss. 5, pp. 1123-1133
Open Access | Times Cited: 20
The Management of Chronic Rhinosinusitis With Nasal Polyps (CRSwNP) With Biologics
A. Wautlet, Claus Bachert, Martin Desrosiers, et al.
The Journal of Allergy and Clinical Immunology In Practice (2023) Vol. 11, Iss. 9, pp. 2642-2651
Closed Access | Times Cited: 17
EUFOREA meeting on defining disease states in allergic rhinitis: towards a unified language in AR
G. K. Scadding, Diego M. Conti, Sophie Scheire, et al.
Frontiers in Allergy (2025) Vol. 5
Open Access
Immunology of Nasal Polyposis and Allergic Rhinitis
Sven Schneider, Julia Eckl‐Dorna
Elsevier eBooks (2025)
Closed Access
Raising the bar in respiratory care by EUFOREA: report of the European Union Parliament Symposium, April 2024
Peter W. Hellings, Diego M. Conti, Xander Bertels, et al.
Frontiers in Allergy (2025) Vol. 6
Open Access
Development and validation of a Delphi consensus-based questionnaire for the multidisciplinary management of type 2 inflammation-related diseases
F.J. Ortiz de Frutos, Carolina Cisneros, José Miguel Villacampa, et al.
Frontiers in Allergy (2025) Vol. 6
Open Access
EUFOREA summit in Brussels 2023: inspiring the future of allergy & respiratory care
Peter W. Hellings, Susanne Lau, Glenis Scadding, et al.
Frontiers in Allergy (2023) Vol. 4
Open Access | Times Cited: 9
Nasal polyp syndrome: a patient-centred term for CRSwNP by EUFOREA
T. Teeling, C. Djouder, Henry Laurens, et al.
Frontiers in Allergy (2024) Vol. 5
Open Access | Times Cited: 3
Multidisciplinary approaches to identifying and managing global airways disease: Expert recommendations based on qualitative discussions
Vibeke Backer, Lars‐Olaf Cardell, Lauri Lehtimäki, et al.
Frontiers in Allergy (2023) Vol. 4
Open Access | Times Cited: 8
Monoclonal antibody or aspirin desensitization in NSAID-exacerbated respiratory disease (N-ERD)?
Dorien Van Broeck, Brecht Steelant, Glenis Scadding, et al.
Frontiers in Allergy (2023) Vol. 4
Open Access | Times Cited: 7
The future of allergic rhinitis management: A partnership between healthcare professionals and patients
Biljana Cvetkovski, Danielle Marie Muscat, Jean Bousquet, et al.
World Allergy Organization Journal (2024) Vol. 17, Iss. 3, pp. 100873-100873
Open Access | Times Cited: 2
EUFOREUM Berlin 2023: Optimizing care for type 2 inflammatory diseases from clinic to AI: A pediatric focus
Diego M. Conti, Vibeke Backer, Beyer Kirsten, et al.
Pediatric Allergy and Immunology (2024) Vol. 35, Iss. 7
Open Access | Times Cited: 2
Multidisciplinary management of type 2 inflammation diseases using a screening tool
Óscar Palomares, Carolina Cisneros, F.J. Ortiz de Frutos, et al.
Frontiers in Allergy (2024) Vol. 5
Open Access | Times Cited: 2
Current goals of NSAID-ERD management: patient-centered approaches involving NSAID desensitization with and without biologics
Irina Bobolea, Jan Hagemann, Marek Sanak, et al.
The Journal of Allergy and Clinical Immunology In Practice (2024) Vol. 12, Iss. 11, pp. 2934-2944
Open Access | Times Cited: 2
Upper airway disease diagnosis as a predictive biomarker of therapeutic response to biologics in severe asthma
Sophie Cottin, V. Doyen, Charles Pilette
Frontiers in Medicine (2023) Vol. 10
Open Access | Times Cited: 5
Addressing the unmet needs in patients with type 2 inflammatory diseases: when quality of life can make a difference
Enrique Gómez de la Fuente, Isam Alobid, Íñigo Ojanguren, et al.
Frontiers in Allergy (2023) Vol. 4
Open Access | Times Cited: 4
Is endoscopic sinus surgery sufficient to modify the evolution of adult AERD? Aspirin desensitization as a maintenance factor: systematic review
Diego M. Conti, Eduardo J. Correa, Glenis Scadding
Frontiers in Allergy (2023) Vol. 4
Open Access | Times Cited: 2
Editorial: 2022 in review: rhinology
Diego M. Conti, Glenis Scadding
Frontiers in Allergy (2024) Vol. 5
Open Access
A clinical study on the relationship between chronic rhinosinusitis and bronchial asthma
Jing Kang, Hui Yee Yong, Zhijuan Zhang, et al.
Frontiers in Medicine (2024) Vol. 11
Open Access
European biologic training course for type 2 inflammation by EUFOREA in 2024: key facts and lessons learned
Diego M. Conti, Vibeke Backer, W.J. Fokkens, et al.
Frontiers in Allergy (2024) Vol. 5
Open Access
Anti-Eosinophil Biologics in Chronic Respiratory Diseases
Huizi Wu, Lan Huang, Yan Liu
Journal of Contemporary Medical Practice (2024) Vol. 6, Iss. 12, pp. 135-142
Closed Access
A Multidisciplinary Approach for Type 2 Allergic Diseases: What Do Biologics Teach Us?
Mauro Maniscalco, Aikaterini Detoraki, Giovanni Sarnelli, et al.
Journal of Personalized Medicine (2023) Vol. 13, Iss. 6, pp. 941-941
Open Access | Times Cited: 1
An update on patient reported outcomes in type 2 inflammation airway disease
C. Pedersen, Christiane H. Haase, Kasper Aanæs, et al.
Current Opinion in Allergy and Clinical Immunology (2022)
Closed Access | Times Cited: 2
Page 1 - Next Page

Scroll to top